Structures by: Ding M.
Total: 44
C30H38O9
C30H38O9
Journal of medicinal chemistry (2020)
a=7.4020(2)Å b=13.4298(4)Å c=26.9766(9)Å
α=90° β=90° γ=90°
C42H44BClMnN6
C42H44BClMnN6
Chemical science (2016) 7, 9 6132-6140
a=19.4894(10)Å b=16.2426(9)Å c=49.107(3)Å
α=90.00° β=90.164(3)° γ=90.00°
C42H44BMnN7,0.5(C4H8O)
C42H44BMnN7,0.5(C4H8O)
Chemical science (2016) 7, 9 6132-6140
a=24.9817(18)Å b=11.9639(9)Å c=26.6933(19)Å
α=90.00° β=95.7654(13)° γ=90.00°
BMS-791325
C36H46ClN5O6S
Journal of medicinal chemistry (2014) 57, 5 1855-1879
a=28.0870(13)Å b=11.9998(6)Å c=10.9846(6)Å
α=90.00° β=90.761(2)° γ=90.00°
C36H34N4O8S2,CH2Cl2
C36H34N4O8S2,CH2Cl2
Organic letters (2015) 17, 2 206-209
a=12.9116(6)Å b=15.1292(7)Å c=18.7417(9)Å
α=90.00° β=90.00° γ=90.00°
C22H16Cl2N2O3,C4H8O2
C22H16Cl2N2O3,C4H8O2
Chemical Science (2011) 2, 10 2035
a=12.5561(5)Å b=12.8030(5)Å c=16.3869(7)Å
α=83.5940(10)° β=83.9170(10)° γ=75.0880(10)°
C17H13NO3
C17H13NO3
Organic & biomolecular chemistry (2012) 10, 16 3178-3181
a=7.3660(4)Å b=9.0252(5)Å c=10.1518(5)Å
α=84.572(2)° β=88.905(2)° γ=89.911(2)°
C34H38Dy2N4O16
C34H38Dy2N4O16
Dalton Transactions (2020)
a=18.8341(9)Å b=8.8537(4)Å c=23.0950(12)Å
α=90° β=90° γ=90°
C36H42Dy2N4O16
C36H42Dy2N4O16
Dalton Transactions (2020)
a=18.6721(16)Å b=9.0807(8)Å c=23.3406(19)Å
α=90° β=90° γ=90°
C38H44Dy2N6O16
C38H44Dy2N6O16
Dalton Transactions (2020)
a=16.0720(14)Å b=16.4037(14)Å c=18.1256(16)Å
α=90° β=100.123(2)° γ=90°
B4Ca2F2I0Li6O10
B4Ca2F2I0Li6O10
Dalton transactions (Cambridge, England : 2003) (2020) 49, 35 12184-12188
a=25.685(2)Å b=3.4697(3)Å c=5.4404(4)Å
α=90° β=90° γ=90°
Piperazinium tetrabromocuprate
Br4Cu,C4H12N2
Journal of Materials Chemistry C (2019) 7, 29 8813
a=10.7447(4)Å b=7.8796(3)Å c=17.5823(8)Å
α=90° β=111.126(5)° γ=90°
USTC-7
C15H7N4O7Zn2
Chem.Commun. (2016) 52, 5734
a=10.267(5)Å b=32.086(5)Å c=6.955(5)Å
α=90.000(5)° β=90.000(5)° γ=90.000(5)°
C23H26BrN3O5
C23H26BrN3O5
Chemical communications (Cambridge, England) (2009) 44 6753-6755
a=9.0411(3)Å b=12.0586(4)Å c=12.8583(4)Å
α=115.6260(10)° β=92.7780(10)° γ=107.0370(10)°
C75H38Cu6N6O36
C75H38Cu6N6O36
CrystEngComm (2014) 16, 41 9586
a=29.627(3)Å b=29.627(3)Å c=29.627Å
α=90.00° β=90.00° γ=90.00°
2-Diethylamino-6-ethyl-6-methyl-3-phenylthieno[2,3-d]pyrimidin-4(3H)-one
C19H23N3OS
Acta Crystallographica Section E (2006) 62, 7 o2862-o2863
a=8.8085(10)Å b=9.5503(11)Å c=22.037(3)Å
α=90.00° β=97.269(2)° γ=90.00°
2-(4-methoxyphenoxy)-3-phenyl-3H-benzo[4,5]furo[3,2-d]pyrimidin-4-one
C23H16N2O4
Acta Crystallographica Section E (2005) 61, 10 o3266-o3268
a=9.3415(12)Å b=10.0584(12)Å c=19.976(3)Å
α=90.00° β=92.262(2)° γ=90.00°
2-Ethoxy-3-phenyl-1-benzothieno[3,2-d]pyrimidin-4(3H)-one
C18H14N2O2S
Acta Crystallographica Section E (2006) 62, 6 o2229-o2230
a=22.4877(18)Å b=11.2298(9)Å c=14.8969(12)Å
α=90.00° β=126.2980(10)° γ=90.00°
2,2,5,5-Tetramethyl-1,6-diphenyl-7,8-diselenabicyclo[4.1.1]octane 7,8-dioxide
C22H26O2Se2
Acta Crystallographica Section E (2004) 60, 9 o1458-o1459
a=9.1930(18)Å b=17.752(4)Å c=12.779(3)Å
α=90.00° β=103.43(3)° γ=90.00°
2-Ethoxy-3-isopropylbenzo[4,5]thieno[3,2-d]pyrimidin-4(3H)-one
C15H16N2O2S
Acta Crystallographica Section E (2005) 61, 9 o2789-o2790
a=13.3930(16)Å b=6.8922(8)Å c=15.4970(18)Å
α=90.00° β=90.00° γ=90.00°
4-Benzylidene-1-phenyl-2-propylamino-1H-imidazol-5(4H)-one
C19H19N3O
Acta Crystallographica Section E (2006) 62, 2 o647-o648
a=11.6442(11)Å b=11.3675(10)Å c=12.8149(12)Å
α=90.00° β=99.058(2)° γ=90.00°
2-(4-Methoxyphenoxy)-1,9-diphenyl-1,9-dihydropurin-6-one
C24H18N4O3
Acta Crystallographica Section E (2006) 62, 3 o1022-o1024
a=8.0020(7)Å b=9.7745(8)Å c=25.255(2)Å
α=90.00° β=90.00° γ=90.00°
3-Benzyl-6-isopropyl-5-methoxy-3H-1,2,3-triazolo[4,5-d]pyrimidin-7(6H)-one
C15H17N5O2
Acta Crystallographica Section E (2006) 62, 5 o1888-o1890
a=7.0800(8)Å b=8.7574(10)Å c=13.0492(15)Å
α=102.369(2)° β=103.511(2)° γ=92.883(2)°
3-(4-Chlorophenyl)-5-ethyl-6-methyl-2-morpholinothieno[2,3-d]pyrimidin- 4(3H)-one
C19H20ClN3O2S
Acta Crystallographica Section E (2006) 62, 7 o2869-o2871
a=8.0455(6)Å b=11.7674(9)Å c=39.887(3)Å
α=90.00° β=90.00° γ=90.00°
(E)-3-Isopropyl-5,5-dimethyl-2-(phenylimino)imidazolidin-4-one
C14H19N3O
Acta Crystallographica Section E (2005) 61, 8 o2640-o2641
a=10.2783(11)Å b=11.4013(11)Å c=11.5930(12)Å
α=90.00° β=90.00° γ=90.00°
2-Morpholino-3-p-tolylbenzo[4,5]thieno[3,2-d]pyrimidin-4(3H)-one
C21H19N3O2S
Acta Crystallographica Section E (2006) 62, 8 o3428-o3429
a=16.693(3)Å b=12.970(2)Å c=17.392(3)Å
α=90.00° β=94.002(3)° γ=90.00°
5-Benzylamino-6-phenyl-2-propylsulfanylthiazolo[5,4-d]pyrimidin-7(6H)-one
C21H20N4OS2
Acta Crystallographica Section E (2006) 62, 1 o88-o90
a=23.3140(6)Å b=23.3140(6)Å c=7.7925(4)Å
α=90.00° β=90.00° γ=90.00°
trans-(+-)-N,N'-Bis(salicylidene)-1,2-cyclohexane-diamine
C20H22N2O2
Acta Crystallographica Section C (1997) 53, 11 1671-1673
a=16.0010(10)Å b=11.821(3)Å c=9.6410(10)Å
α=90.00° β=98.53(3)° γ=90.00°
(+-)- 7,7,9,9-tetramethyl-2,3:4,5-di(naphtho)-1,6,8-trioxa- 7,9-disila-cyclonona-2,4-diene
C24H24O3Si2
Acta Crystallographica Section C (1998) 54, 1 145-146
a=10.6940(10)Å b=13.4810(10)Å c=15.307(2)Å
α=90.00° β=94.320(10)° γ=90.00°
2-(1-Naphthylmethyl)-1H-benzo[d]imidazole
C18H14N2
Acta Crystallographica Section E (2007) 63, 7 o3184-o3184
a=8.4578(16)Å b=9.0329(17)Å c=9.6474(18)Å
α=90.00° β=108.932(3)° γ=90.00°
N^2'^,N^5'^-Diisopropylidenepyrazine-2,5-dicarbohydrazide dihydrate
C12H16N6O2,2(H2O)
Acta Crystallographica Section E (2008) 64, 4 o677
a=7.1924(5)Å b=9.9409(8)Å c=11.0903(9)Å
α=80.261(6)° β=84.605(5)° γ=89.537(6)°
(2<i>S</i>*,3<i>S</i>*,3a<i>S</i>*,6<i>S</i>*,7a<i>R</i>*)-3-Hydroxy- 2-[(2<i>R</i>*,3<i>S</i>*)-3-isopropyloxiran-2-yl]-3,6-dimethyl- 3,3a,5,6,7,7a-hexahydro-1-benzofuran-4(2<i>H</i>)-one
C15H24O4
Acta Crystallographica Section E (2012) 68, 10 o2949
a=6.616(7)Å b=9.261(9)Å c=25.12(3)Å
α=90.00° β=90.00° γ=90.00°
0.5(C96H48In4N8Ni2O20)
0.5(C96H48In4N8Ni2O20)
ACS Catalysis (2018) 8, 5 4583
a=7.07250(10)Å b=33.2883(6)Å c=16.6660(3)Å
α=90.00° β=90.00° γ=90.00°
0.13(C96H48In6N8O20),0.23(O)
0.13(C96H48In6N8O20),0.23(O)
ACS Catalysis (2018) 8, 5 4583
a=7.125Å b=33.622Å c=16.583Å
α=90.00° β=90.00° γ=90.00°
0.13(C96H48In4.36N8O18.01)
0.13(C96H48In4.36N8O18.01)
ACS Catalysis (2018) 8, 5 4583
a=7.0996(4)Å b=33.5115(18)Å c=16.7335(9)Å
α=90.00° β=90.00° γ=90.00°
C25H23N3O
C25H23N3O
Journal of Organic Chemistry (2009) 74, 6874-6877
a=9.8330(5)Å b=10.3533(5)Å c=11.6066(6)Å
α=73.1380(10)° β=70.8640(10)° γ=74.5520(10)°
C26H21ClN2O4
C26H21ClN2O4
Journal of Organic Chemistry (2012) 77, 696-700
a=10.432(2)Å b=10.4650(19)Å c=11.533(2)Å
α=90.692(4)° β=108.767(3)° γ=106.266(4)°
C17H15NO2
C17H15NO2
Journal of Organic Chemistry (2012) 77, 2954-2958
a=19.856(4)Å b=7.3460(13)Å c=20.945(4)Å
α=90.00° β=116.514(2)° γ=90.00°
C10H24Co2O19
C10H24Co2O19
Inorganic Chemistry (2009) 48, 7457-7465
a=9.4058(19)Å b=10.215(2)Å c=11.096(2)Å
α=87.82(3)° β=77.29(3)° γ=70.21(3)°
C10H18CoNa2O16
C10H18CoNa2O16
Inorganic Chemistry (2009) 48, 7457-7465
a=15.723(3)Å b=9.5571(19)Å c=6.1123(12)Å
α=90.00° β=92.83(3)° γ=90.00°
C20H46Na4Ni2O37
C20H46Na4Ni2O37
Inorganic Chemistry (2009) 48, 7457-7465
a=9.6710(7)Å b=10.2810(7)Å c=11.1449(7)Å
α=114.761(4)° β=92.333(4)° γ=93.158(4)°
C20H31Li2Ni3O29.5
C20H31Li2Ni3O29.5
Inorganic Chemistry (2009) 48, 7457-7465
a=9.540(2)Å b=19.812(5)Å c=11.151(3)Å
α=90.00° β=113.684(10)° γ=90.00°
C20.4H10.8In2N1.2O13.4
C20.4H10.8In2N1.2O13.4
Inorganic chemistry (2016) 55, 7 3558-3565
a=15.4979(9)Å b=13.4644(7)Å c=32.4682(18)Å
α=90° β=90° γ=90°
C69H77BFeN7V,6(C4H8O)
C69H77BFeN7V,6(C4H8O)
Inorganic chemistry (2015) 54, 18 9075-9080
a=19.5861(9)Å b=19.5861(9)Å c=76.340(4)Å
α=90.00° β=90.00° γ=120.00°